Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Romina Gallizzi et al.|Frontiers in Pharmacology|2019Cited by 616
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseasesGiulio Cavalli, Charles A. Dinarello, Giuseppe Lopalco et al.|Autoimmunity Reviews|2021Cited by 330
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Florenzo Iannone, Georgina Espígol‐Frigolé et al.|Arthritis & Rheumatology|2021Cited by 165
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Luca Cantarini, Carlo Salvarani et al.|Frontiers in Pharmacology|2016Cited by 88
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyMario Messina, Romina Gallizzi, Chiara Stagnaro et al.|Clinical Rheumatology|2018Cited by 82